Our Experts

Work with Industry Thought Leaders at Every Stage of Your Clinical Research Study

With so much at stake, you want the best minds focused on your clinical trial. ERG delivers, with teams of experts working on every facet.

Nitendra Agarwal, MD

Internal Medicine

Glen Apseloff, MD

Abuse Liability/Clin Pharm

Mark Brody, MD

Neurology/AD

Keith Candiotti, MD

Anesthesiology/Pain

Andria Chastain

Psychiatry/Addiction

Andrew Cutler, MD

Psychiatry/Neurology/Addiction

Clay Dehn, MS

Metabolism/NASH/Clin Pharm

Emanuel DeNoia, MD

Phase 1/Internal Medicine

Stacy Dilzer

Clin Pharm/Renal/Hepatic

Bernadette D’Souza, MD

Psychiatry/Addiction

Judith Dunn, PhD

Drug Development/CNS

Angela Eakin, MD

Phase 1/Family Medicine

Ellen Fields, MD

Drug Development/Regulatory

Ana Fuquay

Alzheimer’s Disease/Neurology

Holly George, RPH, CCP

Pharmacist/Neurology

Daniel Gruener, MD

Psychiatry/Pain/Addiction

Sharon, Hertz, MD

Regulatory

George Konis, MD

Psychiatry/Addiction/Internal Medicine

Luke Kramer

Patient Advocate

David Leiman, MD

Acute & Chronic Pain/Anesthesiology

Suresh Mallikaarjun, MD

Drug Development/Clin Pharm

William Martin, PhD

Drug Development/CNS

Harold Minkowitz, MD

Acute & Chronic Pain/Anesthesiology

Ashley Poole

Psychiatry/Pediatric

Alexander Prezioso, MD

Obstetrics & Gynecology/Phase 1

Denise Roberts, RN

Pain/NASH/ General Medical

Steve Romano, MD

Drug Development/CNS

Janeen Rosales, MS, CCRC

Phase 1/Special Populations

Dennis Ruff, MD

Phase 1/Internal Medicine

Sherwyn Schwartz, MD

Endocrinology/NASH

Stephen Thein, PhD

Sleep/AD

Daniel Umbricht, MD

Translational Medicines/CNS

Kimberly Vanover, PhD

Drug Development/CNS

Richard Walovitch, MD

Imaging/Pharmacology

Peter J. Weiden, MD

Psychiatry

Lori Wright

Psychiatry

Denise Roberts

Pain/NASH/General Medical

Janeen Rosales

Phase 1/Special Populations

Luke Kramer

Patient Advocate

Clayton Dehn

Metabolism/NASH/Clin Pharm

  • Vice President of Clinical Pharmacology Services at Evolution Research Group
  • Published in numerous peer-reviewed journal articles
  • Conducted 160+ Phase I-IV clinical trials with challenging population inclusive of Diabetes, Vulvovaginal Candidiasis, Healthy Volunteers, Hypogonadal, Liver Disease, Coronary Artery Disease, NASH, Postpartum Depression, Alzheimer’s, and many other medical as well as psychiatric indications
  • Commissioner of the Arizona Biomedical Research Commission, Editor-In-Chief of Series of Endocrinology Diabetes and Metabolism and Editorial Board Member of various well-established journals

Dr. Paul Michael Ramirez

Ratings Expert, Rater Training

Dr. Sherwyn Schwartz

Diabetes/NASH

Dr. Bernadette D’Souza

Psychiatry/Addiction

Dr. Daniel Umbricht

Translational Medicine/CNS

Dr. Judith Dunn

Drug Development/CNS

Dr. Andrew Cutler

Psychiatry/ Neurology/Addiction

Dr. Kimberly Vanover

Drug Development/CNS

Dr. William Martin

President Lotus Clinical Research

Andria Chastain

Psychiatry/Addiction

Dr. Harold Minkowitz

Chronic Pain

Dr. David Leiman

Acute and Chronic Pain

Dr. Steve Romano

Drug Development/CNS

Glen Apseloff, MD

Clinical Pharmacology / Human Abuse Potential

  • Founder and Investigator of Ohio Clinical Trials
  • Board Certified in Clinical Pharmacology
  • Holds degrees from Massachusetts Institute of Technology (MIT) and Ohio State University College of Medicine
  • Held multiple teaching positions in clinical pharmacology
  • Served on the editorial board of 3 peer review journals
  • 30+ years of clinical research experience
  • Participated in hundreds of studies
  • Authored over a hundred abstracts and publications
  • Holds two use patents

Dr. Suresh Mallikarjun

Drug Development/Clin Pharm

Dr. Stephen Thein

Sleep/AD

Dr. Mark Brody

Neurology/AD

Dr. Sarah Atkinson

Psychiatry Adult/Pediatric

Dr. Daniel Gruener

Psychiatry/ Pain/Addiction